{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"Eli Lilly是美国的产业资本投资平台，通过战略投资布局成长期与成熟期企业。","sources":[],"related":[{"id":"fa254cc6-22d5-4c8e-b8e9-c84e7b03c2dd","kind":"news","code":"fa254cc6-22d5-4c8e-b8e9-c84e7b03c2dd","name":"Persist AI raises USD 12 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Persist AI完成1200万美元A轮融资","eventDate":"2025-05-19T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:34:26.715Z","englishUpdatedAt":"2026-10-15T17:20:00.196Z","reviewedAt":"2026-10-15T17:20:00.196Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6831f437b8dacec78b8671f97c08c98cb0949b047b471e29e8d421a9831bd1bf","companyId":"3a6a12a5-512d-4e2f-a7c7-2f659a501b5c","foundedYear":null,"logoUrl":null,"path":"/news/fa254cc6-22d5-4c8e-b8e9-c84e7b03c2dd"},{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","kind":"news","code":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","name":"Superluminal Medicines raises USD 120 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成1.2亿美元A轮融资","eventDate":"2024-09-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T09:54:27.118Z","englishUpdatedAt":"2026-10-15T17:19:59.178Z","reviewedAt":"2026-10-15T17:19:59.178Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dad4fa4c64ac255cdb6fbb7b3cdf1ed0bfd304e3c8f6cb55d15dd5d95c6b3db7","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef"},{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","kind":"news","code":"22da73b7-c7eb-4a01-b246-146e4f248acc","name":"Superluminal Medicines raises USD 60 million in Series B financing","nameBasis":"translated-title","summary":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成B轮融资，融资金额6000万美元","eventDate":"2026-09-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:42:26.621Z","englishUpdatedAt":"2026-10-15T20:50:21.999Z","reviewedAt":"2026-10-15T20:50:21.999Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e8e7b1b012c19476316906130fd4ae28ebac9db6102a8c78bc6bf24e9a1a83b0","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc"}],"path":"/institutions/eli-lilly","canonical":"https://uniquebase.ai/institutions/eli-lilly"}